Uranium Royalty Corp., a Vancouver company with 14 employees that owns slices of other miners' production rather than mining anything itself, closed its fiscal year in April with revenue of $257.9m. The prior year's figure was $15.6m. Almost the entire jump came from one quarter, in which the company booked $204.3m of revenue and $49.2m of net income by selling physical uranium it had accumulated. Net income for the year was $55.5m, against a loss of $5.7m the year before.

That print, plus a corporate reshuffle — the company filed to deregister its shares with the Securities and Exchange Commission, withdrew a C$150m shelf and filed a new $128.6m one tied to an employee share plan — moved the stock 22.1% in a session. Over 30 sessions it is up 55.5%, from $2.65 to $4.12, with the volume concentrated in the first week of August at roughly triple the following week's.

Strip that one name out and the uranium group's headline month largely disappears. Cameco rose 11.9%, Centrus 21.9% and NexGen 15.3%, against 10.3% for the Global X Uranium ETF and single-digit gains at most peers. All four names are lower over three months, Cameco by 13.1% and NexGen by 17.9%.

The producer's earnings fell for a reason that already happened

Cameco, the Saskatoon miner that also refines and fabricates reactor fuel and owns 49% of reactor-builder Westinghouse, reported second-quarter net income of $25m, down 92% year over year. The cause is traceable: the prior-year quarter carried roughly $170m of one-time revenue from the Czech Dukovany two-reactor award, and Westinghouse swung to a $10m loss on Cameco's share from $126m of earnings. Underneath, adjusted EBITDA was $391m, production guidance held at 19.5-21.5 million pounds, and full-year revenue guidance was raised to C$3.32-3.57bn from C$2.85-3.06bn. Management said it has contracts covering more than 28 million pounds of average annual deliveries.

The complication is what the drawdown did to the multiple. Cameco's trailing price/earnings ratio was 104x when this desk last worked through it in May, at a $49.9bn market value. The market value is now $42.6bn and the trailing multiple is 165.8x — the shares fell, and earnings fell faster. Forward multiples tell the recovery story instead: 59.6x on this year's consensus and 37.1x on next year's, against a consensus price target near $130, about a third above the current price. Westinghouse has filed confidentially for a US listing, which would put a public price on a stake Cameco bought into for $7.9bn with Brookfield in 2023.

The enricher's decline is earned

Centrus Energy, the Maryland supplier of enrichment services that is building commercial centrifuges at Piketon, Ohio, grew second-quarter revenue 14% to $176.1m — but gross margin fell to 28.3% from 34.9%, operating income dropped 69% and net income fell 42%. The stock is down 31% over six months and no cheaper for it: forward price/earnings of 74.3x sits fractionally above the trailing 75.8x, because consensus expects earnings per share to fall 42.9% this year. Free cash flow is negative during the build-out.

The order book argues the other way. Backlog reached $4.5bn through 2040, with $2.4bn of previously contingent enrichment volume now under definitive agreement, alongside a $900m Department of Energy task order excluded from that figure. Management says utilities remain in wait-and-see mode until centrifuges deliver.

NexGen Energy has no revenue and won't until roughly 2030. Its Rook I project in Saskatchewan received a construction licence from the Canadian Nuclear Safety Commission in March, and the shaft-sinking contract — over half of total capital cost — was awarded in line with the C$2.2bn estimate. It is also where the dilution sits: diluted shares are up 23.7% year over year after a C$953m raise, and price-to-book is 5.19x for a mine that produces nothing.

The physical market splits the same way

Spot uranium is about $86.50 a pound, down from a $100.25 peak in January. The long-term contract price utilities actually transact on — 87% of deliveries — reached $90 a pound and has printed near $94, the highest since 2008. Cameco calls it mid-$90s heading to $100; NexGen cites a five-year forward of $105. The term curve supports the bull case. The daily price does not.

Every one of the four still trades with its 50-day average below its 200-day, a condition Cameco entered in June and has not left. Centrus and Uranium Royalty improved off the worst of it in the past week; the producer and the developer did not.

The setup

Where it stands — A 29% group month is one micro-cap's non-repeating windfall; the other three roughly matched the sector ETF and remain below April levels. Would confirm — Term uranium contract prices holding above $90 a pound alongside 2026 utility contracting volumes near the 150-million-pound replacement rate. Would invalidate — Cameco missing its 19.5-21.5 million pound production guidance, or Centrus's $2.4bn of definitive enrichment backlog reverting to contingent. Watch next — Cameco's third-quarter results in early November, and any public filing of the Westinghouse S-1 registration statement. Valuation — Cameco 165.8x trailing, 59.6x forward; Centrus 75.8x trailing versus 74.3x forward; Uranium Royalty 9.96x trailing, above 1,000x forward.